EGFR and neoplasm: With regard to the tumour suppressor function of MAGL, it was shown in this context that MAGL can inhibit the transactivation of epidermal growth factor receptor (EGFR)-associated signalling pathways as well as proinflammatory proteins such as COX-2 and tumour necrosis factor (TNF)-α.